Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AFRY publishes the Annual- and Sustainability Report for 2023

AFRY has today published the Annual- and Sustainability Report for 2023 and it is available on the company website afry.com .The Report presents the company’s performance during the year, business strategy and sustainability work. The full year 2023 was characterised by a healthy demand for AFRY’s services, where we are well positioned within the global energy and industrial transition. 2023 saw net sales of SEK 27 billion, which corresponds to a total growth of 15 percent. “We continue to strengthen our position within the green

Post-Stabilisation Notice

Post Stabilsation NoticeDZ Bank AG: Post-Stabilisation Notice Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. DZ BANK AG (contact: Ralph Ockert; telephone: +49 69 7447 7051) herebygives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/2014) was undertaken by the Stabilising Managers named below in relation to the offer of the following securities. The security to be stabilised:    Issuer:

Post-Stabilisation Notice

Post -Stabilisation NoticeDZ Bank AG: Post-Stabilisation Notice Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. DZ BANK AG (contact: Ralph Ockert; telephone: +49 69 7447 7051) herebygives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/2014) was undertaken by the Stabilising Managers named below in relation to the offer of the following securities. The security to be stabilised: Issuer:

Post-Stabilisation Notice

Post-Stabilsation NoticeDZ Bank AG: Post-Stabilisation Notice Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. DZ BANK AG (contact: Ralph Ockert; telephone: +49 69 7447 7051) herebygives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/2014) was undertaken by the Stabilising Managers named below in relation to the offer of the following securities. The security to be stabilised: Issuer:

Key information relating to the preferential rights issue to be carried out by poLight ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA, HONG KONG OR THE UNITED STATES, OR ANY OTHER JURISDICTION INWHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THISANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREINReference is made to the stock exchange announcement published poLight ASA (the "Company" or "poLight") on 22 March 2024 regarding the contemplated partly underwritten rights issue in the Company, to raise gross proceeds of up to NOK 160 million (the "Rights Issue"). Key

Spinomenal Teams up with Slovakian Market Leader Niké

Spinomenal, the leading iGaming content provider, has agreed a new content partnership with Slovakian giant, Niké. The integration will be completed via the Easit platform, part of Synot Group.As one of Slovakia’s star performers, joining forces with Niké enables Spinomenal to amplify its presence in the region. Niké’s casino players will have seamless access to Spinomenal’s stunning selection of titles, which includes big hitters Queen of Ice, Wildfire Fruits, and Wacky Monkey.  Lior Shvartz, CEO for Spinomenal commented: “Teaming up with Niké adds momentum to our ongoing mission of

Probi publishes Annual Report for 2023

Probi's Annual Report and Sustainability Report for 2023 are now available on the company website, www.probi.com under Investor Relations: https://www.probi.com/investor-relations/financial-reports/ This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 12.10 CET on 25 March 2024. For further information, please contact: Per Lindblad, CFO, ProbiPhone +46 46 286 89 41, E-mail: per.lindblad@probi.com ABOUT PROBIProbi[®] is a global Group that focuses exclusively on

Akobo Minerals AB releases updated and improved production mine plan for first 12 months

Oslo, 25.03.2024 – Akobo Minerals AB  (Euronext and Frankfurt: AKOBO) (OTCQX:AKOBF). The Scandinavian-based Ethiopian gold exploration and mining company has today released an improved gold production mine plan for its first 12 months of mining operations in the Eastern and Western winzes (tunnels). The updated plan improves the current production schedule and will have a significant effect on the initial revenue and EBITDA from the Segele mine. Most of the

Saab receives order for Carl-Gustaf from NATO Support and Procurement Agency

Saab has received an order for the man-portable, multi-role weapon system Carl-Gustaf[®] from the NATO Support and Procurement Agency (NSPA). The order value is approximately EUR 60 million (SEK 700 million) and the contract period is 2024-2027.The order is placed on behalf of four NATO member nations within a framework agreement between Saab and the NSPA regarding Carl-Gustaf, including ammunition and equipment. “We are honoured that the NSPA once again has chosen our trusted, reliable and effective Carl-Gustaf system,” says Görgen Johansson, head of Saab’s business area Dynamics.

Kamux Corporation's Annual Report 2023 has been published

Kamux Corporation, Stock Exchange Release, 25.3.2024 at 13:00 Kamux Corporation's Annual Report 2023 has been published Kamux Corporation's Annual Report 2023 has been published. The Annual Report consists of the Annual Review, the Board of Director’s Report, the Financial Statements and the Auditor’s Report, as well as the Corporate Governance Statement and the Remuneration Report 2023. Kamux publishes the Finnish language version of the Annual Report in accordance with the European Single Electronic Format (ESEF) reporting requirements as an XHTML file. In line with the ESEF

EQT Exeter Real Estate Income Trust announces acquisition of 450,000 square-foot industrial property in Georgetown, TX for over $60M

The transaction represents the REIT’s first property acquisitionEQT Exeter Real Estate Income Trust, Inc. (“EQRT”) today announced its first acquisition, purchasing 110 Southeast Inner Loop Road in Georgetown, Texas for $60.9 million. EQRT acquired the property with proceeds from the sale of 6.22 million Class E units of its operating partnership to EQT Exeter Holdings US, Inc., an affiliate of EQRT’s sponsor. The 449,642 square-foot property is fully occupied by GAF Energy LLC (“GAF Energy”), a leading producer of solar roofing, on a long-term lease. The newly built, cutting-edge

ChromoGenics initiates cost reduction program

ChromoGenics adjusts cost structure to meet market challenges and ensure long-term growth. Stockholm, 2024-03-25 - ChromoGenics (NASDAQ: CHRO), a leading supplier of dynamic glass products and solutions, announced today the decision to adjust its cost structure to address market challenges and ensure long-term growth. Over the past year, ChromoGenics has achieved significant improvements in its production process, resulting in increased efficiency and enhanced production capacity. The production processes are stable and contribute to a positive gross margin, providing a solid

OddsJam Launches Progressive Partnership with Birches Health

OddsJam, the premium data platform for sports bettors, has struck a progressive partnership with cutting-edge responsible gaming and behavioral health treatment company Birches Health.The specialized healthcare service provides resources, education, and care for behavioral addictions, with a core focus on gambling and gaming disorders. Thanks to this agreement, OddsJam users will gain seamless access to a wide selection of Responsible Gaming resources and treatment services. OddsJam prides itself on helping its online community bet smarter, and this includes quickly understanding

Svenska Aerogel secures substantial pilot order from key customer in the electric vehicle battery industry

Svenska Aerogel has received its first order from a recently introduced key customer within the transport sector – a European supplier to the electric vehicle (EV) industry with a global presence. This order marks an important milestone in the collaboration. The size of the order, 560 kg of Quartzene[®], significantly exceeds the usual size for a pilot order, demonstrating great potential.The size of the pilot orders Svenska Aerogel typically receives ranges from 50 to 150 kg, highlighting the large size of this pilot run.   Tor Einar Norbakk, CEO of Svenska Aerogel: ”This order

IQwave™ Receives Certification for Tumour Treatment in Singapore

Scandinavian ChemoTech is pleased to announce that its tumour treatment product; IQwave™, has been officially certified for use in Singapore.   This certification represents an achievement in the Company's mission to provide innovative solutions for cancer treatment, further solidifying IQwave's commitment to improving patient outcomes.   IQwave's advanced tumour treatment technology offers a minimally invasive approach to targeting and treating tumours with exceptional precision, while minimizing the impact on surrounding healthy tissue. The certification from regulatory

Report from the extraordinary general meeting of Rightbridge Ventures Group AB on 25 March 2024

At the extraordinary general meeting (the “EGM”) of Rightbridge Ventures Group AB, reg. no. 559058-5807, (the “Company”), on 25 March 2024 the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the meeting, which have previously been published and are available on the Company’s website, rightbridge.se. · The EGM resolved, in accordance with the major shareholders proposal, that the board of directors, for the period until the end of the next annual general meeting, shall consist of

Notice of extraordinary general meeting in Biokraft International AB (PUBL)

At the request of 1Vision Biogas AB, reg.no. 559460-3374, (“1Vision Biogas”) which after completion of the public takeover offer to the shareholders of Biokraft International AB (publ), 556528-4733, (the “Company”) holds more than 90 percent of all the shares and votes in the Company, the shareholders of the Company are hereby convened to the Extraordinary General Meeting (“EGM”) to be held on Monday 15 April 2024, at 10:00, at Cirio Advoktbyrå, Biblioteksgatan 9, in Stockholm.   Participation Shareholders who wish to participate in the EGM must:   -          be registered in

Notice of Annual General Meeting

25 March 2024   Hydro Hotel, Eastbourne, Plc (“Hydro Hotel” or the “Company”)   Notice of Annual General Meeting   Hydro Hotel, Eastbourne, Plc announces that Notice convening the one hundred and twenty ninth Annual General Meeting of the Company for 11.30 am on 16 April 2024 at the Hydro Hotel, Mount Road, Eastbourne, has been posted to shareholders in the Company. The Directors of Hydro Hotel accept responsibility for the content of this announcement.   Enquiries:   Hydro Hotel, Eastbourne, Plc Telephone: +44 1323 431 200 Sally Gausden

BE Group will close loss-making operations in the Baltics

BE Group OÜ, which includes sales unit and warehouse in Maardu (Estonia) and sales units in Riga (Latvia) and Kaunas (Lithuania) has, despite extensive improvement measures taken to reach profitability, continued to generate losses. Decision has therefore been taken to close operations in Baltics. Net sales in 2023 was SEK 268 M and the operating result amounted to SEK -10 M. The closure will take place during the second quarter and affects approximately 25 employees. One-off cost is estimated to amount to approximately SEK 35 M and will affect the result for the current year. The

Correction: Repurchase of Truecaller B shares in week 12, 2024

This pressrelease is a correction of this mornings press release sent out 8.45 am CET where the daily transaction values was wrong. During 18 March 2024 and 22 March 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 337,209 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in

Beware of Easter dangers!

As Easter festivities approach, pet owners are urged to be vigilant to protect their beloved dogs and cats from potential dangers lurking amidst the celebrations. According to Agria's chief veterinarian, Lotta Möller, Easter decorations such as eggs, feathers, and flowers can pose serious risks to pets, often resulting in emergency visits to the veterinarian. “A common type of injury is when the dog or cat chews on something inappropriate that gets stuck in the stomach and intestines or poisons the animal. This could involve Easter decorations, remnants of Easter eggs, or

Getinge and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing

Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution, launching today, is a breakthrough within allogenic cell therapy manufacturing. “Both our companies are dedicated to helping the development of life-saving therapies gain momentum. CellRev’s technology combined with our latest bioreactor systems has the potential to transform allogeneic cell therapy manufacturing,” says Sean Herdlein, Vice President Bio-Processing at Getinge. The cell therapy market is

There are no items matching the current filter
There are no more items matching the current filter
Back to top